Article
Fibroblast growth factor receptor 4 polymorphisms are associated with coronary artery disease.
Genetic testing and molecular biomarkers - 1 Aug 2012
Chen Hao, Tong Jiabin, Zou Tong, Shi Haifeng, Liu Junpeng, Du Xin, Yang Jiefu, Ma Changshen
Abstract excerpt
Fibroblast growth factor receptor 4 (FGFR4) plays crucial roles in vascular smooth muscle cell proliferation and atherosclerosis and, therefore, may potentially affect the development of coronary artery disease (CAD). The aim of this study was to investigate the association between FGFR4 polymorphisms and the susceptibility to CAD in the Chinese population. Two polymorphisms, rs192201146G/A (Asp756Asn) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
